Demand for spinal stenosis treatment will increase through 2036, with thoracic and lumbar fusion devices at a 40.0% share as the leading product type segment. The market value stood at USD 9.8 billion in 2025 and is forecast to reach USD 16.4 billion by 2036 across key growth regions.